ML281 是一种强效、选择性的喹喔啉基 STK33 抑制剂，IC50 值为 14 nM。

GSK8612是一种高度选择性和高效的Tank结合激酶-1（TBK1）抑制剂，对重组TBK1的pIC50为6.8。

Midostaurin (PKC412; CGP 41251) 是一种口服活性、可逆的多靶点蛋白激酶抑制剂，抑制PKCα/β/γ、Syk、Flk-1、Akt、PKA、c-Kit、c-Fgr、c-Src、FLT3、PDGFRβ和VEGFR1/2的IC50值范围为22到500 nM。它还上调内皮一氧化氮合酶（eNOS）基因表达，并表现出强大的抗癌作用。

4μ8C（IRE1抑制剂III）是一种靶向IRE1α的小分子抑制剂。

Sotrastaurin (AEB071) 是一种高效且口服活性的泛 PKC 抑制剂，对 PKCθ、PKCβ、PKCα、PKCη、PKCδ 和 PKCε 的 Ki 值分别为 0.22 nM、0.64 nM、0.95 nM、1.8 nM、2.1 nM 和 3.2 nM。

Chelerythrine Chloride是一种强效、细胞渗透的蛋白激酶C抑制剂，IC50为660 nM。此外，它抑制Bcl-XL-Bak BH3肽的结合，IC50为1.5 μM，并将Bax从Bcl-XL中置换出来。Chelerythrine Chloride诱导凋亡和自噬。

ILK-IN-1 is an ILK inhibitor with IC50 of 0.6 μM.

WNK463 is a potant With-No-Lysine (WNK) kinase inhibitor with IC50s of 5/1/6/9 nM for WNK1/2/3/4.

ILK-IN-3 is an integrin linked kinase inhibitor.

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

CMPD1 is a selective inhibitor of non-ATP-competitive p38 MAPK-mediated MK2 phosphorylation with apparent Ki (Kiapp) of 330 nM.

ILK-IN-2 is a ILK inhibitor.

GSK429286A selectively inhibits ROCK1 and ROCK2 with the IC50 value of 14 nM and 63 nM, respectively.

SAR407899 is a potent, ATP-competitive ROCK inhibitor woth Ki value of 36 nM/41 nM for human ROCK/Rat ROCK respectively.

RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and 6.2 nM, respectively, and has anti-invasive and antitumor activities.

SRPIN340 is an inhibitor of serine/arginine-rich protein kinase SRPK1 with IC50 of 0.89 μM.

ZT-12-037-01 is a potent and selective STK19 inhibitor with an IC50 value of 24.04nM